Journal of Clinical Pediatrics ›› 2020, Vol. 38 ›› Issue (2): 146-.doi: 10.3969/j.issn.1000-3606.2020.02.016

Previous Articles     Next Articles

Single-center drug epidemiological study of warfarin in children

 XU jinghan1, GU zhichun2, LI Hao1,3, SHI Fanghong2, ZHANG Shunguo1   

  1. 1.Department of Pharmacy, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine; 2. Department of Pharmacy, Renji Hospital, Shanghai Jiao Tong University School of Medicine; 3. Clinical Research Center, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
  • Published:2020-02-20

Abstract: Objective To summarize the application of warfarin in children. Methods Clinical data of 362 children who used warfarin from January 2014 to December 2018 were collected and retrospectively analyzed. Results Among the 362 patients treated with warfarin, 210 (58.0%) were male patients and 152 (42.0%) were female patients. Of them 194 (53.6%) came from department of cardiothoracic surgery and 125 (34.5%) came from Department of Cardiology. Diseases needed warfarin therapy were mainly congenital heart disease (242 cases, 66.9%) and Kawasaki disease (74 cases, 20.4%). Pediatric patients treated with warfarin were mainly from East China (262 cases, 72.4%). Conclusion The use of warfarin in children is very different from that in adults. Children's anticoagulant therapy and research require special attention.

Key words: warfarin; epidemiology; single-center; child